Aer Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$3M
- Investors
-
9
Aer Therapeutics General Information
Description
Developer of a novel mucolytic therapy designed to treat muco-obstructive lung diseases. The company is developing AER-01, an inhaled thiol-reducing agent that targets and liquefies airway mucus plugs, enabling patients with chronic obstructive pulmonary disease and asthma to improve lung function and quality of life.
Contact Information
Website
www.aertherapeutics.comCorporate Office
- 400 West North Street
- Suite 112
- Raleigh, NC 27603
- United States
Corporate Office
- 400 West North Street
- Suite 112
- Raleigh, NC 27603
- United States
Aer Therapeutics Timeline
Aer Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC | 18-Aug-2026 | $3M | Completed | Clinical Trials - Phase 2 | ||
| 7. Debt - General | 28-Mar-2025 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series A) | 24-Jan-2025 | Completed | Clinical Trials - General | |||
| 5. Later Stage VC (Series B) | Completed | Clinical Trials - General | ||||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A) | 09-Dec-2022 | Completed | Clinical Trials - General | |||
| 2. Grant | $18M | Completed | Startup | |||
| 1. University Spin-Out | 28-May-2014 | Completed | Startup |
Aer Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Aer Therapeutics Comparisons
Industry
Financing
Details
Aer Therapeutics Competitors (3)
One of Aer Therapeutics’s 3 competitors is Verona Pharma, a Corporate Backed or Acquired company based in London, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verona Pharma | Corporate Backed or Acquired | London, United Kingdom | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Savara | Formerly VC-backed | Yardley, PA |
Aer Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Aer Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Aer Therapeutics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Pappas Capital | Venture Capital | Minority | ||
| UCSF Innovation Ventures | Venture Capital | Minority | ||
| NovaUCD | Accelerator/Incubator | |||
| Canaan Partners | Venture Capital | Minority | ||
| Hatteras Venture Partners | Venture Capital | Minority |
Aer Therapeutics FAQs
-
When was Aer Therapeutics founded?
Aer Therapeutics was founded in 2014.
-
Where is Aer Therapeutics headquartered?
Aer Therapeutics is headquartered in Raleigh, NC.
-
What is the size of Aer Therapeutics?
Aer Therapeutics has 10 total employees.
-
What industry is Aer Therapeutics in?
Aer Therapeutics’s primary industry is Drug Discovery.
-
Is Aer Therapeutics a private or public company?
Aer Therapeutics is a Private company.
-
What is Aer Therapeutics’s current revenue?
The current revenue for Aer Therapeutics is .
-
How much funding has Aer Therapeutics raised over time?
Aer Therapeutics has raised $51M.
-
Who are Aer Therapeutics’s investors?
Pappas Capital, UCSF Innovation Ventures, NovaUCD, Canaan Partners, and Hatteras Venture Partners are 5 of 9 investors who have invested in Aer Therapeutics.
-
Who are Aer Therapeutics’s competitors?
Verona Pharma, Avalyn Pharma, and Savara are competitors of Aer Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
